Jones Hill Capital’s Nuvation Bio NUVB Stock Holding History

Jones Hill Capital’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,383,031	Closed	-$10.2M	–	32
2026 Q1	$10.2M	Buy	+2,383,031	New	+$13.3M	2.19%	15

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jones Hill Capital's NUVB Position: Q2 2026 in Review

Jones Hill Capital sold out of Nuvation Bio (NUVB) in Q2 2026, closing a stake of 2,383,031 shares — an estimated $10.2M sold.

Jones Hill Capital first reported a position in NUVB in Q1 2026 and held it in 1 quarter. The position peaked at $10.2M in Q1 2026. 242 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

Jones Hill Capital reported no remaining Nuvation Bio position as of Q2 2026 after selling out during the quarter.
Jones Hill Capital sold 2,383,031 Nuvation Bio shares in Q2 2026, an estimated $10.2M.
Jones Hill Capital first reported a position in Nuvation Bio in Q1 2026 and held it in 1 quarter.
Jones Hill Capital's Nuvation Bio position peaked at $10.2M in Q1 2026.
242 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Jones Hill Capital's 13F filing for Q2 2026, filed 13 Aug 2026.